Cart
sales@molnova.com
DIF-3
CAS No. 113411-17-9
DIF-3( —— )
Catalog No. M35425 CAS No. 113411-17-9
DIF-3 is a chemical compound that acts by activating GSK-3β to facilitate the degradation of cyclin D1 and c-Myc, resulting in reduced expression levels of these proteins.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 141 | In Stock |
|
| 5MG | 235 | In Stock |
|
| 10MG | 351 | In Stock |
|
| 25MG | 569 | In Stock |
|
| 50MG | 812 | In Stock |
|
| 100MG | 1071 | In Stock |
|
| 500MG | 2187 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDIF-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionDIF-3 is a chemical compound that acts by activating GSK-3β to facilitate the degradation of cyclin D1 and c-Myc, resulting in reduced expression levels of these proteins.
-
DescriptionDIF-3 reduces the expression levels of cyclin D1 and c-Myc by facilitating their degradation via activation of GSK-3β. DIF-3 inhibits Wnt/β-catenin signaling pathway-related proteins in DLD-1 cells. DIF-3 exerts a strong antiproliferative effect on the human cervical cancer cell line HeLa by inducing cyclin D1 degradation and inhibiting cyclin D1 mRNA expression.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin | GSK-3 | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number113411-17-9
-
Formula Weight272.72
-
Molecular FormulaC13H17ClO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (366.68 mM; Ultrasonic )
-
SMILESCCCCCC(=O)c1c(O)cc(OC)c(Cl)c1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Naoya Kubokura , et al. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo. J Pharmacol Sci. 2015 Apr;127(4):446-55.?
molnova catalog
related products
-
N-(3-Methoxybenzyl)-...
N-3-methoxylBenzyllinolenicamide induces osteogenic differentiation and subsequent bone formation of mesenchymal stem cells by activating the canonical Wnt/β-catenin signaling pathway that can be used for osteoporosis research.
-
ICG-001
ICG-001 is an antagonist of Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CBP) with IC50 of 3 μM.
-
Isx 9
ISX9 was necessary to activate neuron-specific genes as neurogenesis inducer.
